MedPath

LIDOCAINE HCL 0.2% AND DEXTROSE 5% INJ

LIDOCAINE HCL 0.2% AND DEXTROSE 5% INJ

Discontinued
DIN Number

00828599

Drug Class

Human

Market Date

Dec 31, 1990

Company
HC

baxter corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00828599
AIG Number0201281002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
C01BB01 LIDOCAINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification24:04.04.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

DEXTROSEActive
Strength: 50 MG / ML
Monograph: DEXTROSE
LIDOCAINE HYDROCHLORIDEActive
Strength: 2 MG / ML
Monograph: LIDOCAINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.